JFS Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.56K | Hold |
45
| – | – | ﹤0.01% | 1076 |
|
|
2026
Q1 | $7.6K | Hold |
45
| – | – | ﹤0.01% | 1048 |
|
|
2025
Q4 | $7.59K | Hold |
45
| – | – | ﹤0.01% | 1079 |
|
|
2025
Q3 | $6.5K | Hold |
45
| – | – | ﹤0.01% | 1025 |
|
|
2025
Q2 | $5.69K | Hold |
45
| – | – | ﹤0.01% | 1039 |
|
|
2025
Q1 | $5.82K | Hold |
45
| – | – | ﹤0.01% | 1061 |
|
|
2024
Q4 | $6.01K | Hold |
45
| – | – | ﹤0.01% | 1058 |
|
|
2024
Q3 | $6.62K | Hold |
45
| – | – | ﹤0.01% | 1011 |
|
|
2024
Q2 | $6.25K | Hold |
45
| – | – | ﹤0.01% | 971 |
|
|
2024
Q1 | $6.24K | Sell |
45
-641
| -93% | -$87.5K | ﹤0.01% | 1023 |
|
|
2023
Q4 | $93.3K | Sell |
686
-253
| -27% | -$30.9K | 0.01% | 314 |
|
|
2023
Q3 | $115K | Hold |
939
| – | – | 0.01% | 266 |
|
|
2023
Q2 | $119K | Hold |
939
| – | – | 0.01% | 257 |
|
|
2023
Q1 | $121K | Hold |
939
| – | – | 0.01% | 255 |
|
|
2022
Q4 | $123K | Hold |
939
| – | – | 0.01% | 251 |
|
|
2022
Q3 | $110K | Hold |
939
| – | – | 0.01% | 275 |
|
|
2022
Q2 | $110K | Hold |
939
| – | – | 0.01% | 275 |
|
|
2022
Q1 | $122K | Hold |
939
| – | – | 0.01% | 270 |
|
|
2021
Q4 | $143K | Sell |
939
-177
| -16% | -$27.4K | 0.01% | 261 |
|
|
2021
Q3 | $180K | Buy |
1,116
+921
| +472% | +$155K | 0.02% | 229 |
|
|
2021
Q2 | $32K | Hold |
195
| – | – | ﹤0.01% | 319 |
|
|
2021
Q1 | $29K | Hold |
195
| – | – | 0.01% | 303 |
|
|
2020
Q4 | $30K | Sell |
195
-70
| -26% | -$10K | 0.01% | 292 |
|
|
2020
Q3 | $36K | Buy |
265
+220
| +489% | +$29.8K | 0.01% | 264 |
|
|
2020
Q2 | $6K | Buy |
+45
| New | +$5.74K | ﹤0.01% | 419 |
|
|
2018
Q2 | – | Sell |
-35
| Closed | -$4K | – | 508 |
|
|
2018
Q1 | $4K | Buy |
35
+32
| +1,067% | +$3.55K | ﹤0.01% | 436 |
|
|
2017
Q4 | $0 | Buy |
+3
| New | +$321 | ﹤0.01% | 544 |
|
|
2016
Q3 | – | Sell |
-120
| Closed | -$10K | – | 502 |
|
|
2016
Q2 | $10K | Hold |
120
| – | – | ﹤0.01% | 386 |
|
|
2016
Q1 | $10K | Hold |
120
| – | – | ﹤0.01% | 391 |
|
|
2015
Q4 | $14K | Hold |
120
| – | – | ﹤0.01% | 363 |
|
|
2015
Q3 | $12K | Hold |
120
| – | – | 0.01% | 317 |
|
|
2015
Q2 | $15K | Hold |
120
| – | – | 0.01% | 316 |
|
|
2015
Q1 | $14K | Hold |
120
| – | – | 0.01% | 319 |
|
|
2014
Q4 | $12K | Hold |
120
| – | – | ﹤0.01% | 354 |
|
|
2014
Q3 | $11K | Hold |
120
| – | – | ﹤0.01% | 328 |
|
|
2014
Q2 | $10K | Buy |
+120
| New | +$9.45K | ﹤0.01% | 331 |
|
Other funds holding IBB
CB
JFS Wealth Advisors's IBB Position: Q2 2026 in Review
JFS Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 45 shares worth $8.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.
JFS Wealth Advisors first reported a position in IBB in Q2 2014 and has held it in 36 quarters since. The position peaked at $180K in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- JFS Wealth Advisors held 45 shares of iShares Biotechnology ETF worth $8.56K as of Q2 2026.
- JFS Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1076 holding.
- JFS Wealth Advisors first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 36 quarters since.
- JFS Wealth Advisors's iShares Biotechnology ETF position peaked at $180K in Q3 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.